Welcome : Guest

MediciNova, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about MediciNova, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 32 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-38845
Price: $1600
Company Type: Public
Pages: 35
Date: November 2016
Market Data Tables: 32

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Asthma Patients......4
Table 1: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......4
Table 2: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......5
Asthma Drugs......6
Table 3: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......6
Chronic Obstructive Pulmonary Disease (COPD) and Asthma......7
Table 4: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......7
Multiple Sclerosis Drugs......8
Table 5: Relapsing-Remitting Multiple Sclerosis (RRMS) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union (EU), US, Rest of World (RoW)......8
Table 6: Multiple Sclerosis Disease Occurrence by Type Worldwide (2015) - Percentage Breakdown by Volume for Begin MS, Primary Progressive MS, Relapsing-Remiting MS, and Secondary Progressive MS......9
Table 7: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2015) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Redused Working Time, and Tests......10
Table 8: Specialty Multiple Sclerosis Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......11
Tcelna Imilecleucel-T......12
Table 9: No. of Tcelna (Imilecleucel-T) Secondary Progressive Multiple Sclerosis Patients by Category in the US (2015) - Percentage Breakdown for Primary Progressive MS Patients, Relapsing-Remitting MS Patients, and Secondary-Progressive MS Patients......12
Liver Cancer......13
Table 10: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......13
Respiratory......14
Table 11: Respiratory Drugs (Asthama, COPD & Allergic Rhinitis) Market Worldwide (2015) in US$ Million......14
Table 12: Respiratory Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Claritin and Clarinex, Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......15
Table 13: Respiratory Virus Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......16
Table 14: Specialty Respiratory Conditions Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......17
Neuro Stimulation......18
Table 15: Neuro Stimulation Market Worldwide (2015) in US$ Million......18
Neurology......19
Table 16: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......19
Neuromodulation......20
Table 17: Neuromodulation Market by Category in the US (2015) - Percentage Share Breakdown by Value for Deep Brain, Sacral Nerve, Spinal Cord, and Vagus Nerve......20
Table 18: Neuromodulation Market by Company Worldwide (2014) - Percentage Breakdown by Value Sales for Boston Scientific Corporation, Cyberonics, Inc., Medtronic, Inc., and St. Jude Medical, Inc.......21
Neurosurgery......22
Table 19: Neurosurgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 Years, 15-44 Years, 45-64 Years, and 65+ Years......22
Rescue Therapy for Asthma Attacks & COPD......23
Table 20: Rescue Therapy for Treatment of Asthma Attacks & COPD Exacerbations Market Worldwide (2015) in US$ Million......23
Stem Cell Transplantation......24
Table 21: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Solid Tumors by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......24
Table 22: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS), Non-Malignant Disorders and Others......25
Anaesthesia & Respiratory Products......26
Table 23: Market Shares of Leading Anaesthesia & Respiratory Products Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Braun & Company Limited, CareFusion Corporation, Covidien Public Limited Company, Smiths Group Plc, Teleflex, Inc., Vital Signs, Inc., and Others......26
Drugs for Relapsing-Remitting Multiple Sclerosis (RRMS)......27
Table 24: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by No. of Patients for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......27
Table 25: Market Shares of Leading Drug Brands for Relapsing-Remitting Multiple Sclerosis (RRMS) Worldwide (2015) - Percentage Breakdown by Value for Avonex, Betaseron, Copaxone, Gilenya, Laquinimod, Rebif, Tysabri, and Others......28
Multiple Sclerosis Therapeutics......29
Table 26: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......29
Nerve Growth Factor (NGF)......30
Table 27: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co., Ltd., Staidson (Beijing) Biopharmaceuticals Co., Ltd., Xiamen Bioway Pku Co., Ltd., and Others......30
Neuromodulation Devices......31
Table 28: Market Shares of Leading Neuromodulation Device Manufacturers Worldwide (2014) - Percentage Breakdown by Value for Boston Scientific Corporation, Cyberonics, Inc., Medtronic, Inc. and St. Jude Medical, Inc.......31
Neuromodulators......32
Table 29: Market Shares of Leading Neuromodulator Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ipsen and Galderma S.A., Allergan and Others......32
Neurophysiology Research Products......33
Table 30: Market Shares of Leading Neurophysiology Research Products Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Ambu A/S, Natus Medical Inc., Rhythmlink International, LLC, and Others......33
Neurosurgery......34
Table 31: Market Shares of Leading Neurosurgery Service Providers in the US (2015) - Percentage Share Breakdown by Value for Integra LifeSciences Corporation, and Others......34
Respiratory Therapeutics......35
Table 32: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......35